NC
FLGT icon

NewSquare Capital’s Fulgent Genetics FLGT Stock Holding History

NewSquare Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12
Closed -$347 – 471
2023
Q4 		$347 Buy
+12
New +$321 ﹤0.01% 440
2023
Q3 		– Sell
-52
Closed -$1.93K – 684
2023
Q2 		$1.93K Hold
52
– – ﹤0.01% 526
2023
Q1 		$1.62K Buy
52
+7
+16% +$225 ﹤0.01% 591
2022
Q4 		$1.34K Buy
+45
New +$1.61K ﹤0.01% 540

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

NewSquare Capital's FLGT Position: Q1 2024 in Review

NewSquare Capital sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 12 shares — an estimated $347 sold.

NewSquare Capital first reported a position in FLGT in Q4 2022 and held it in 4 quarters. The position peaked at $1.93K in Q2 2023. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • NewSquare Capital reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • NewSquare Capital sold 12 Fulgent Genetics shares in Q1 2024, an estimated $347.
  • NewSquare Capital first reported a position in Fulgent Genetics in Q4 2022 and held it in 4 quarters.
  • NewSquare Capital's Fulgent Genetics position peaked at $1.93K in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on NewSquare Capital's 13F filing for Q1 2024, filed 8 May 2024.